Pfizer set to ask FDA to approve booster for those 18 and older
Nov 09, 2021
Peter Chin-Hong, M.D., an infectious-disease physician at the University of California, San Francisco, said there is “some value” in young people getting a booster to protect older relatives...
CDC panel gives support to new COVID-19 booster shots
Sep 13, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
A second booster dose resulted in 123,869 fewer hospitalizations and 5,524 fewer deaths versus a single-dose campaign.
U.S. Surgeon General issues call to counter ‘urgent threat’ of vaccine misinformation
Jul 16, 2021
U.S. Surgeon General Vivek Murthy, M.D., on Thursday called on tech companies, healthcare workers, journalists and ordinary Americans to do more to fight vaccine misinformation.
FDA approval of new COVID-19 boosters could come by Friday
Sep 07, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
Health officials recommend spring COVID-19 booster for older adults
Feb 29, 2024
A second booster is appropriate as long as at least four months have passed since a person’s last COVID-19 shot.
CDC: Vaccinated more likely to die during omicron wave if they got J&J shot
Mar 25, 2022
However, breakthrough infections among J&J vaccine recipients were similar or lower compared with the other vaccines.
Updated COVID-19 vaccines will roll out mid-September, officials say
Aug 25, 2023
The new vaccines will target the XBB.1.5 coronavirus subvariant and offer some protection for closely related strains.
Pfizer vaccine booster restores nearly full protection, company says
Oct 21, 2021
The trial is the first randomized, controlled COVID-19 vaccine booster study to provide efficacy results.
FDA approves new COVID-19 booster shots
Sep 11, 2023
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.